Skye Bioscience, Inc. Gain (Loss) on Disposition of Other Assets
Skye Bioscience, Inc. (SKYE) reported Gain (Loss) on Disposition of Other Assets of -$597.27 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2026-08-14
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for the quarter ending 2026-06-30 was -$589.66K.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for the quarter ending 2026-03-31 was -$7.62K.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for the quarter ending 2025-12-31 was $0.00.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for the quarter ending 2025-09-30 was $0.00.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for fiscal 2025 was $0.00.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for fiscal 2024 was -$10.79K, a 364.56% decline from fiscal 2023.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for fiscal 2023 was $4.08K.
- Skye Bioscience, Inc. gain (loss) on disposition of other assets for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$589.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$597.27K 10-Q · filed 2026-08-14 | -$597.27K derived: sum of 3 quarters · filed 2026-08-14 | -$597.27K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$7.62K 10-Q · filed 2026-05-11 | -$7.62K derived: sum of 2 quarters · filed 2026-05-11 | -$7.62K derived: sum of 3 quarters · filed 2026-05-11 | -$7.62K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | -$10.79K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$10.79K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$10.79K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $4.08K 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |